4777 East Galbraith Road, Cincinnati, Ohio 45236  Ph: 513-686-5260

The Cancer Center at The Jewish Hospital
 
The Jewish Hospital has long been known as Cincinnati's Oncology Center. We participate in the latest studies and research, and are at the forefront of groundbreaking treatment. Our cancer program is approved by the American College of Surgeons Commission on Cancer.

Radiation Oncology

The staff remains committed to providing the highest quality care to patients receiving radiation. This includes using state of the art principles for simulation and treatment planning as well as care of skin reactions and other radiation induced treatment effects. The department plays a major role in the support of the Blood and Marrow Transplant Program. 

Five years ago, the radiation oncology and urology departments pioneered a new treatment modality for prostate cancer in the region. Transperineal implantation of radioactive seeds has become the standard of care for our patients with prostate cancer. More than 500 cases have now been performed and the results have been presented at national forums. The hospital is currently the regional center for seed implantation with a large regional and national referral base.

We provide the following services:

• Advanced Radiation Therapy
• Brachytherapy
• Simulations
• CT Scanning
• 3D Computer Treatment Planning

 
The Blood and Marrow Transplant Program
at The Jewish Hospital

Formerly known as the Stem Cell Transplant Program, the Blood and Marrow Transplant Program is the only adult bone marrow transplant program in the Tristate. The Jewish Hospital is among the nation's best in this field, participating in revolutionary clinical trials as well as providing new chances at life for patients with leukemia, non-Hodgkin's lymphoma and a host of other diseases.
 

Qualified. . . .

"Each member of the team, from the staff nurses to the nurse clinicians to the physicians, worked together to support me physically and emotionally, inspiring me with hope and encouraging me to fight my disease."
- Jodi Mitchell. Received allogeneic stem cell transplant at The Jewish Hospital, July 1996

A Proven Program Focused on Success

When physicians choose to refer patients to The Jewish Hospital Blood and Marrow Transplant Program, they're choosing hope for their patients – hope for a good outcome, a promising future, a return to everyday life.

This success-oriented program is also responsive to physicians' needs with an easy referral process, weekly updates and the speedy return of patients to the care of their oncologist.

Our suburban Cincinnati location provides easy access for patients and their families living in Ohio, Kentucky and Indiana. Research protocols ensure that all patients are evaluated to receive leading-edge treatments. And the 23-bed intensive care unit in our new facility offers state-of-the-art care that minimizes stress and maximizes comfort for patients and their families.

The Jewish Hospital has been serving bone marrow transplant patients and their referring oncologists since 1989. Started for autologous transplants, The Jewish Hospital's program was redesigned and improved in 1993 to encompass new services, including high dose chemotherapy and allogeneic transplants. In July 1996, the University of Cincinnati's bone marrow transplant program was consolidated into The Jewish Hospital program.

Outcomes that Give Hope

The outcomes of our growing bone marrow transplant program rival national statistics - and offer the best of treatments close to home. Oncologists across the region refer patients to The Jewish Hospital Blood and Marrow Transplant Program for transplants, high dose chemotherapy and leukemia treatment. We encourage oncologists to refer transplant candidates early in the course of their treatment to improve their chances of success.

Every capability to Fight Cancer

The Jewish Hospital Blood and Marrow Transplant Program offers the full range of transplant and treatment options:

• Autologous stem cell transplant
   
• Allogeneic stem cell transplant
  Matching donors: related and unrelated
  Mismatched donors: related and unrelated
   
• Leukemia treatment to ensure consistency of care and speed readiness for transplant, if needed
  Induction therapy
  Consolidation therapy
  High dose chemotherapy
   
• On-site bone marrow harvest and peripheral stem cell pheresis
  Many of our autologous transplant patients undergo peripheral stem cell pheresis. Less invasive than traditional bone marrow harvest, it does not require general anesthesia. Our clinical research studies are evaluating new drugs to help prime the stem cells for harvest and reduce the number of collections needed for a transplant.
   
• Inpatient transplants with outpatient follow-up
   
• In the planning stages: Outpatient transplants
  Most treatment is done in the outpatient setting with admission reserved for those requiring inpatient care. Intended mainly for autologous transplants, outpatient transplant requires that candidates meet very strict criteria to qualify. They benefit by staying in their own familiar home environment or designated housing located near the hospital during al of their treatment and recovery needs. 

 
 
Nurturing. . . .

Patient-Friendly Facilities

The Blood and Marrow Transplant Program and Unit were moved from The Jewish Hospital of Cincinnati to The Jewish Hospital in northeastern Cincinnati in 1997. Created with particular concern for patient and family convenience, the 23-bed intensive care unit is designed to make every aspect of treatment as stress-free as possible.

All of the services patients need are located on site, including Hoxworth Blood Center. Central line catheters are inserted on the unit. The large private rooms each have their own bathroom. There are laundry facilities and a kitchen for families. The spacious accommodations allow family members to stay overnight.

The 23 HEPA-filtered inpatient beds include:

• Two specially constructed rooms for patients needing radium implants
• Four full intensive care unit rooms, large enough to handle all equipment needed by a patient with complications
• Full monitoring capabilities

The unit's flexibility and capabilities provide for all patient needs including any complications. Therefore patients remain in the Blood and Marrow Transplant Unit for all of their treatment and stay with nurses and other caregivers who understand their special needs. Minimizing in-house transfers benefits both patients and their families. 

We'll Keep You Informed

A physician's call is all it takes to begin an evaluation for transplant. Our office manager will schedule an appointment with the patient and obtain all necessary background information from the physician's office. Next, the patient consults with one of our marrow transplant physicians and a nurse coordinator, with the goal of making an informed decision about proceeding with treatment. Once the patient and physician agree to proceed, our team handles all medical and administrative details.

Each week, the patient's physician will receive an update from us on the patient's condition. We welcome questions and input at any time. Once the transplant process is complete, autologous transplant recipients should be back to their oncologist's care within four weeks. Allogeneic transplant patients require weekly follow-up care here for up to a year. After that, they return to their oncologist for care.

Continuity of Care for Patients

To help patients feel comfortable with our staff, we assign them a nurse clinician for their entire inpatient stay, and another for their outpatient follow-up. Even on the transplant unit, we make every effort to provide patients with the same staff nurses.

Nurse clinicians provide continuity of care for the patient, the family and our physicians. They are part of each patient's pre-admission testing and teaching process, and coordinate all details of a patient's transplant. Each morning, they evaluate their patients' laboratory work and their status, and report to the attending physician. In addition, nurse clinicians serve as the family's resource for medical, emotional and practical life issues.

A Dedicated Team

Our team approach helps to ensure the most comprehensive care for patients. In weekly multi-disciplinary meetings, we discuss each patient and how to best meet his or her particular needs.

Our medical director and associate directors bring many years of successful, leading-edge transplant experience to patients. Our nursing staff consists of more than 60 registered nurses, many of whom are oncology-certified and specifically trained in critical care. Nurse clinicians, research nurses, pharmacists, social worker, staff psychologist, dietitian and chaplain are team members experienced in the care of the patient receiving high dose chemotherapy.

Empathetic. . . .

Clinical Research Offers Latest Treatments

From their first evaluation, patients are offered the opportunity to participate in clinical research protocols. They're evaluated for eligibility in numerous treatment protocols and clinical trials, including pharmaceutical studies on antibiotics, antifungal drugs and drugs that affect cell counts.

We participate in trials and report our research and outcomes data to:

• Southwest Oncology Group
• National Marrow Donor Program
• International Bone Marrow Transplant Registry/Autologous Bone Marrow Transplant Registry
• Ohio Bone Marrow Transplant Consortium

Support Groups Continue the Healing

Because we know that life after a transplant will be challenging, we offer patients a support group. Our transplant networking group for patients who have undergone a transplant meets monthly.

Insurance Coverage

We participate in most major insurance plans. We will work with patient insurance carriers to maximize coverage and reimbursement.

Contact the Cancer Center at The Jewish Hospital at:

4777 East Galbraith Road
Cincinnati, Ohio 45236
Outpatient Services 513-686-5260
Blood and Marrow Transplant Unit / Program 513-686-5482